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Lymphatic Endothelium Forms Integrin-Engaging
3D Structures during DC Transit across Inflamed
Lymphatic Vessels
A´lvaro Teijeira1, Saray Garasa1, Rafael Pela´ez1, Arantza Azpilikueta2, Carmen Ochoa2, Diego Marre´3,
Magda Rodrigues4, Carlos Alfaro2, Cristina Auba´3, Salvatore Valitutti4, Ignacio Melero2,5,7 and
Ana Rouzaut1,6,7
Dendritic cell (DC) transmigration across the lymphatic endothelium is critical for the initiation and sustenance of
immune responses. Under noninflammatory conditions, DC transit across the lymphatic endothelial cell (LEC)
has been shown to be integrin independent. In contrast, there is increasing evidence for the participation of
integrins and their ligands in DC transit across lymphatic endothelium under inflammation. In this sense, we
describe the formation of ICAM-1 (CD54)-enriched three-dimensional structures on LEC/DC contacts, as these
DCs adhere to inflamed skin lymphatic vessels and transmigrate into them. In vitro imaging revealed that under
inflammation ICAM-1 accumulated on microvilli projections surrounding 60% of adhered DCs. In contrast, these
structures were scarcely formed in noninflammatory conditions. Furthermore, ICAM-1-enriched microvilli were
important in promoting DC transendothelial migration and DC crawling over the LEC surface. Microvilli
formation was dependent on the presence of b-integrins on the DC side and on integrin conformational affinity
to ligand. Finally, we observed that LEC microvilli structures appeared in close vicinity of CCL21 depots and that
their assembly was partially inhibited by CCL21-neutralizing antibodies. Therefore, under inflammatory
conditions, integrin ligands form three-dimensional membrane projections around DCs. These structures offer
docking sites for DC transit from the tissue toward the lymphatic vessel lumen.
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INTRODUCTION
Dendritic cells (DCs) perform an array of different functions
ranging from immune activation to tolerance (Morel and
Turner, 2011). DCs are the most potent antigen-presenting
cells in the body. Under infection or inflammation, DCs or
their precursors are recruited into the tissue guided by
chemokine cues produced by the damaged tissue (Shortman
and Naik, 2007). Once in the tissue, immature DCs capture
and process antigen, become mature upon microbiological or
inflammatory stimulation, and migrate toward the draining
lymph nodes through lymphatic vessels (Alvarez et al., 2008).
There exists a minor, but continuous, DC intravasation into the
lymphatic vessels under nonpathological conditions, which is
instrumental in the induction of tolerance to self-antigens
(Steinman et al., 2003, Ohl et al., 2004).
However, under inflammation, DC trafficking via afferent
lymphatic vessels increases markedly. During the maturation/
activation process, DCs change their repertoire of chemokine
receptors (i.e., increased CCR7 expression), which enables
them to promptly respond to the chemokines secreted
by the lymphatic endothelium (i.e., CCL21 and CCL19)
(Martin-Fontecha et al., 2003).
Nevertheless, although leukocyte egress from blood into
tissues constitutes an extensively studied phenomenon
(von Andrian and Mackay, 2000, Shulman et al., 2012),
DC entry into lymphatic capillaries has been more recently
addressed and constitutes a growing area of research (Pflicke
and Sixt, 2009).
Leukocyte movement into the initial lymphatic vessels is
facilitated by the specific morphological characteristics of
their endothelium. These capillaries present an interrupted
basal membrane, composed of collagen IV, laminins, perle-
can, and nidogen (Pflicke and Sixt, 2009), and a dispersed,
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button-like, distribution of their inter-endothelial junctional
complexes. Lymphatic vessels are bound by anchoring
filaments that, under high interstitial pressure, pull to open
the vessel walls in order to drain fluid (Saharinen et al., 2004).
All of these morphological features render more permissive
three-dimensional structures for trespassing cells when
compared with blood capillaries. Thus, dendritic cell traffic
across lymphatic vessels under steady-state conditions has
been recently demonstrated to be integrin independent
(La¨mmermann et al., 2008): leukocytes access the initial
lymphatic endothelium through the discontinuities present in
the basal membrane and, subsequently, cross the endothelial
layer through inter-endothelial contacts devoid of intercellular
junctions (Pflicke and Sixt, 2009). An increasing number of
reports have demonstrated the upregulation of adhesive
molecules such as E-selectin and the integrin ligands ICAMs
and vascular cell adhesion molecule-1 (VCAM) on lymphatic
endothelial cells (LECs) under inflammation (Johnson
and Jackson, 2010, Vigl et al., 2011). Furthermore, we and
others have demonstrated how b2 and b1 integrin blockade
decreases DC migration to the lymph nodes under
inflammatory conditions (Podgrabinska et al., 2009, Rouzaut
et al., 2010, Nitschke´ et al., 2012). Interestingly, active
epitopes of aLb1 (LFA-1) integrin are induced in human
dendritic cells after exposure to chemokines such as CCL21
(Eich et al., 2011), produced by lymphatic endothelial cells.
All these findings led us to search for the presence of
integrin-engaging membrane structures on LECs. In this work,
we offer morphological evidence for the involvement of three-
dimensional LEC membrane structures enriched in integrin
ligands as DC transit into lymphatic vessels from mouse and
human tissues. Furthermore, b2-integrin blockade on DCs
inhibited the formation of such endothelial microvilli protru-
sions. In addition, we observe CCL21 depots in close vicinity
to such microvilli-like LEC structures; we also observed that
CCL21-blocking antibodies limited microvilli appearance.
This is, to the best of our knowledge, a previously unreported
description of these subcellular structures in lymphatic capil-
laries, as visualized both on cultured LEC monolayers and in
explanted human and mouse dermal tissue.
RESULTS
ICAM-1-enriched clusters are observed on inflamed mouse
dermal lymphatic vessels interacting with DCs
To explore the cell-to-cell interactions between DCs and LECs,
we added bone marrow (BM)–derived mouse DCs onto
oxazalone-inflamed ear explants. A strong accumulation of
ICAM-1 was detected on the LEC surface in contact with
incoming DCs (Figure 1a), both when DCs adhered to LECs
or when they were actively transmigrating into lymphatics. In
fact, there was a 4-fold increment in the number of adhered
DCs surrounded by ICAM-1-enriched structures on inflamed
versus noninflamed samples. (Figure 1b). Interestingly, these
increments returned to baseline levels when the LFA-1 integrin
was blocked on DCs before adding them to the inflamed ear
tissue, in spite of the existence of intense ICAM-1 staining on
inflamed LECs (Figure 1c). These results demonstrate the
importance of LFA-1 availability on the DC side for these LEC
membrane projections to protrude. Percentages of DCs that
showed ICAM-1 accumulations are summarized in Figure 1d.
We also calculated the percentages of DCs adhered to the
vessels, the percentage of DCs actively traversing the vessel
wall, and the percentage of DCs already inside the vessels
(Supplementary Figure S1A online). As expected, the number
of cells inside the vessel increased under inflammation and
was drastically reduced when the experiments were con-
ducted with LFA-1-preblocked DCs. To address whether
endogenous DCs replicate the behavior of BM-derived DCs,
we repeated the experiments using endogenous DCs obtained
from a crawl-out assay (as described in Materials and
Methods). In Figure 1e, ICAM-1 enrichment around such
adhered DCs could be detected on LYVE-1þ lymphatic
vessels. Finally, we also demonstrated the presence of
VCAM-1 in LEC microvilli-like structures in mouse explanted
tissue, although VCAM was expressed at lower intensities than
ICAM-1 (Supplementary Figure S1B online).
In vitro–tumor necrosis factora–treated lymphatic endothelial
cells protrude ICAM-1-enriched microvilli in contact with DCs
Next, we performed confocal imaging on DCs adhered to and
actively transmigrating across LEC monolayers treated with
tumor necrosis factora (TNFa). According to the results on
explanted tissue, in vitro–inflamed LECs expressed ICAM-1 at
bright intensities, with ICAM-1 being concentrated around
adhered or transmigrating DCs (Figure 2a). These projections
appeared only on the LEC surface in contact with DCs,
but were not present on DC-deprived zones or when DCs
were adhered to noninflamed monolayers (Figure 2a and b).
When quantified, we only observed one instance of ICAM
enrichment among 49 adhered DCs to noninflamed control
monolayers. More interestingly, the same structures were
found around DCs adhering LECs through artificial extracel-
lular matrices established on top of inflamed monolayers
(Figure 2c). This is particularly relevant because, in tissues,
DCs access the lymphatic lumen from the basal aspect of the
endothelium after traversing the extracellular matrix.
Similar to the results obtained with mice explants, we
detected VCAM expression on inflamed LEC microvilli-like
structures formed around adhered DCs (Supplementary Figure
S1D online). Interestingly, CD31/PECAM-1 could not be
detected on LEC microvilli, but only around DCs undergoing
transmigration (Supplementary Figure S1E and F online).
Finally, in order to study whether these structures were
specific to the DC lineage, we repeated the experiments
using phorbol 12-myristate 13-acetate/ionomicyn-activated
peripheral blood mononuclear cells or purified resting
CD4þ T lymphocytes as adhering cells. As shown in
Supplementary Figure S2A and B online, ICAM-1-enriched
endothelial cell projections were also formed around adhered
lymphocytes.
To provide evidence on the dynamics of ICAM-1 interven-
tion on DC adhesion, we performed time-lapse video micro-
scopy of DCs actively adhering to inflamed endothelial
monolayers. As shown in Figure 2d and Supplementary
Video 1 online, ICAM-1-enriched structures were formed
upon DC-LEC contact and accompany DCs throughout the
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transendothelial migration process. In fact, 60% of adhered
DCs presented ICAM-1 enrichments, and the majority of these
initiated transmigration. It is noteworthy that all the DCs
transmigrating across the cytoplasm of LECs (transcellular
migration) presented microvilli-like structures (Supplementary
Video 2 online), and were only observed under inflammatory
conditions. In some instances (37% of total migrating DCs),
we observed ICAM-1 movement accompanying lateral DCs
drifting on the LEC surface toward inter-endothelial bound-
aries (Supplementary Video 1 online).
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Figure 1. ICAM-1-enriched endothelial microvilli are detected around dendritic cells (DCs) adhered to, or actively transmigrating across, lymphatic endothelial
cells (LECs) in inflamed mouse dermal tissue. (a) Confocal image reconstructions of whole-mount ear skin preparations (maximum projection, 400.65mm),
showing ICAM-1 accumulation (green, arrows) around exogenously added bone marrow-DCs (BM-DCs; CMDFA-blue) migrating into LYVE-1 inflamed lymphatic
vessels (red). Right panels, digital magnification: (I) DCs in transendothelial migration, (II) or adhered. (b) Confocal reconstructions as in a, where DCs were
added to noninflamed skin. (c) Same as in a, but adding DCs pretreated with an anti-LFA-1 blocking antibody. (d) Quantification of LECs adhered to DCs
presenting ICAM-1 enrichments. Data represent mean±SEM. At least six microscopic fields from two different mice and 45 DCs per condition were analyzed.
Mann–Whitney U-test, **Po0.01. (e) Image reconstructions of skin-out crawled DCs adhered to mouse ear lymphatic capillaries. ICAM accumulations around
adhered (arrow) or traversing (arrowhead) DCs are denoted. Bars¼ 20mm.
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Figure 2. In vitro analysis of ICAM-1 microvilli-like projections around transmigrating dendritic cells (DCs). (a) Confocal microscopy images (maximum
projection) of ICAM-1 (Alexa-488, green) staining on inflamed and noninflamed lymphatic endothelial monolayers that presented adhered or transmigrating DCs
(blue). A sectional XZ view is shown to reveal the spike-shaped structures. Results are representative of five experiments independently performed. (b) Histogram
plot of ICAM-1 (green) and DC (red) fluorescence intensity on inflamed and noninflamed lymphatic endothelial cells (LECs). (c) Confocal reconstruction of ICAM-1
staining on LEC microvilli protruding into an artificial extracellular matrix. The cartoon on the left represents a schematic view of the in vitro setting. Numbers
correspond to cells that presented this structure among all DCs quantified. Red, Alexa-633-Phalloidin; blue, CMTMR-DC; green, Alexa-488-ICAM-1. (d) Time
series showing enrichments in ICAM-1 (CMTMR, red) on DC/LEC contact areas (ICAM-1, green) during adhesion and transmigration. TEM, transendothelial
migration; TNFa, tumor necrosis factora. Bars¼ 20mm.
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Integrins participate in DC adhesion to LECs through
microvilli-like structures
To clarify whether integrin engagement was required for
the formation of the microvilli-like structures on LECs, we
repeated the adhesion experiments using DCs that had
been preincubated with anti-integrin b1- and anti-integrin
b2-neutralizing mAbs separately or in combination. As shown
in Figure 3a, single b2 integrin blockade significantly reduced
this phenomenon, although only simultaneous b2 and
b1 integrin blockade was able to completely abolish it
(Figure 3b). In addition, b-integrin-blocked DCs showed
impaired crawling and transmigration across preinflamed
LEC monolayers (Figure 3c and Supplementary Video 3
online). As a result, the transmigration events were reduced
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Figure 3. Blockade of b-integrins on dendritic cells (DCs) impaired the formation of microvilli-like structures by inflamed lymphatic endothelial cells (LECs).
(a) Confocal images (maximum XZ and XY projections) showing ICAM-1 microvilli (green) formed around b-integrin-blocked DCs (blue) adhered to LECs. (b) Pie
charts summarizing the percentages of ICAM-1þ microvilli-like structures around DCs treated as in a. (c) Percentages of DCs at different stages of transmigration
across LECs. Mean of three experiments ±SEM. At least 35 DCs were analyzed per condition. **Po0.01, Student’s t-est. (d) Representative time-lapse captures
showing b-integrin-blocked DCs (red) migrating across ICAM-1 LECs (green). (e) Quantification of the number of DCs transmigrated across monolayers of inflamed
or noninflamed LECs in Boyden-chamber assays (mean of three experiments). In all the experiments, IgG treatment was included as a control. (f) In vivo analysis of
footpad-injected CD45.1þ DC migration to the popliteal nodes of CD45.2þ recipient mice, after being pretreated, or not, with b-integrin-blocking antibodies.
Data from two experiments are shown (n¼ 5). TEM, transendothelial migration. Bars¼ 20mm.
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to a minimum (1 out of 45 cells analyzed) when b1- and
b2-integrins had been preblocked (Figure 3c). This result was
corroborated by time-lapse video analyses that showed how
b-integrin-blocked DCs neither clustered ICAM-1 on LECs
around them nor transmigrated across inflamed LECs
(Figure 3d and Supplementary Video 3 online). Next, we
quantified the percentage of DCs that transmigrated across
inflamed and noninflamed LEC monolayers after being,
or not, incubated with b-integrin-blocking antibodies. From
the results summarized in Figure 3e, we concluded that
b-integrins participate in DC transmigration under inflamma-
tion, but have almost no impact on DC migration under
noninflammatory conditions. Finally, to provide evidence in
an animal model, in vitro–generated mouse CD45.1þ DCs
were injected into the footpads of CD45.2þ recipient mice,
and DC recovery in the lymph nodes was analyzed by flow
cytometry. We observed that DC migration to the lymph
nodes was increased when the footpads had been preinflamed
by TNFa. Notably, DC pretreatment with an anti-LFA-1-
blocking antibody reduced DC migration to the draining
lymph nodes under inflammatory conditions (Figure 3f).
Active forms of LFA-1 are present in close contact with LEC
microvilli projections toward adhered DCs
Next, we searched for the presence of the LFA-1 high-affinity
conformation mAb24 epitope (Dransfield and Hogg, 1989) on
LEC surface in contact with adhered DCs. As shown
in Figure 4a, mAb24 epitope clusters polarized to
DC/LEC-contacting areas. To support the relationship between
the presence of integrin active conformation epitopes and the
formation of microvilli-like structures, we quantified the
number of microvilli-surrounded DCs, adding DCs expressing
graded amounts of mAb24 on their membrane. These different
DC populations were obtained by in vitro differentiation of
CD14þ blood monocytes in the presence of IL-4-GM-CSF
(low mAb24 epitope), IL-4-GM-CSF plus lipopolysaccharide
(medium mAb24 epitope), and granulocyte-macrophage
colony-stimulating factor (GM-CSF) plus IFNa (high mAb24
epitope). As shown in the histograms presented in Figure 4b,
the brighter the signal for mAb24 staining on DCs, the higher
the number of microvilli accumulations on LECs.
CCL21 has been described as a cytokine that induces
extended high-affinity integrin conformers (Constantin et al.,
2000, Shamri et al., 2005). As described in Figure 5a, we
observed instances of CCL21 coassociation with adhered DCs
and ICAM-1 staining present in LEC microvilli projections.
In fact, 70% of ICAM-1-surrounded DCs adhered at distances
smaller than DC size (2mm) from CCL21 depots. Interestingly,
when LECs were preincubated with an anti-CCL21-blocking
antibody, significantly fewer ICAM-1þ microvilli were
induced (Figure 5b). These results imply that CCL21 somehow
contributes to the formation of such structures.
Lymphatic vessels in inflamed human dermis accumulate
ICAM-1 in LEC regions in contact with DCs
Finally, we provided evidence obtained from human skin
explants inflamed ex vivo with TNFa treatment. As is shown in
Figure 6a, dermal lymphatic endothelium formed membrane
protrusions enriched in ICAM-1 toward endogenous dendritic
cells adhered to its surface. In fact, we observed these ICAM-1
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Figure 4. High-affinity LFA-1 epitopes are accumulated in dendritic cell (DC)/lymphatic endothelial cell (LEC)-interacting regions. (a) Confocal images (XY and
XZ maximum projection) showing mAb24 active epitope (red) and ICAM-1 (green) co-immunostaining on DCs adhered to LECs. Only DC areas in contact with
inflamed LECs showed ICAM-1/mAb24 colocalization (arrows). Lower graph represents the polarization of mAb24 clusters toward DC/LEC-contacting regions.
Inset shows mAb24 staining on DCs. The dotted line limits LEC surface. (b) Upper histograms correspond to mAb24 expression in different DC populations as
determined by flow cytometry. Lower graph shows the percentage (mean±SEM) of ICAM-1þ clusters around DCs adhered to inflamed LECs. At least 11 fields
and 70 cells were analyzed per condition. Student’s t-test, **Po0.01. MFI, mean fluorescence intensity.
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enrichments in 8 out of 10 DCs analyzed in skin samples
obtained from three different donors. Interestingly, we could
not detect any ICAM-1 accumulation around endogenous DCs
adhered to lymphatic vessels when the tissue had not been
inflamed (Figure 6b). Furthermore, under noninflammatory
conditions, the levels of ICAM-1 staining on LEC capillaries
were negligible, thus ruling out the intervention of ICAM-1 on
DCs in the formation of these structures.
Finally, we explored the distribution of total (Figure 6c) and
active b2 integrin (Figure 6e) in DC areas in contact with
LEC surface. b2 integrin (CD18) was expressed by DCs and
distributed toward the regions interacting with lymphatic
vessels, with this also being evident in homotypic DC
contacts. Interestingly, small clusters of the CD18 active
epitope (mAb24) were oriented on DCs toward the surface
of the lymphatic vessel, with brighter intensities on those
DCs that adhered to the vessels (Figure 6d).
DISCUSSION
The lymphatic vasculature has an important role in immune
cell trafficking toward the lymph nodes. Although DC transit
under steady-state conditions occurs at a slow pace, after
infection or inflammation DCs enter en masse into these
vessels, in order to induce and shape an immune response in
the draining lymph nodes (Steinman et al., 2003). This
increased cell migration should be accompanied by an
endothelial structural adaptation. In fact, a recent report has
provided determining clues in this regard. Working with a
mouse model of pulmonary infection, conclusive confocal
evidence has been presented supporting the transformation of
the button-like adhesive structures characteristic of lymphatic
capillaries into continuous zipper-like junctions (Yao et al.,
2012). Even though experiments published by Michael Sixt’s
group demonstrated integrin-independent leukocyte transit
under noninflammatory conditions, the inflammation-driven
changes of the lymphatic endothelial phenotype justify the
conscript of integrins under such conditions. In fact, we and
others have demonstrated that integrin ligands are induced on
lymphatic endothelial cells under inflammation. Indeed, the
inhibition of integrin ligands in mice significantly reduced the
number of exogenously injected DCs that reached the lymph
nodes under inflammation (Johnson and Jackson, 2008;
Podgrabinska et al., 2009; Rouzaut et al., 2010).
According to these previous observations, here we describe
the presence of ICAM-1-enriched microvilli structures on LECs
that are involved in DC adhesion and transmigration across
the lymphatic endothelium only under inflammatory condi-
tions. Furthermore, we provide ex vivo and in vitro evidence
of the intervention of LFA-1 integrins in this process, as
concluded from experiments performed in inflamed mouse
ear explants and in inflamed human dermal lymphatic vessels.
These results contrast with the participation of integrin ligands
in leukocyte transit across blood capillaries, which occurs
irrespective of the presence of inflammatory mediators.
A proactive role of the endothelium to facilitate leukocyte
adhesion and transmigration was discovered almost 10 years
ago by two different groups (Barreiro et al., 2004, Carman and
Springer, 2004). These authors showed how, upon leukocyte
LFA-1 and VLA-4 engagement, ICAM-1 and VCAM form cup-
like structures on the blood endothelial surface facing the
luminal side of the vessel. These structures constituted a focus
of molecular dialog between the adhered leukocyte and the
endothelial cytoskeleton (Barreiro et al., 2005, Cambi et al.,
2006, Barreiro et al., 2007). We speculate that the same type
of molecular pathways may be involved in inflamed LECs, as
the structure and composition of the membrane projections
are alike.
Despite such similarities, our findings raise intriguing ques-
tions about the functionality of these finger-shaped structures
as formed by LECs. Their presence in blood vessels can be
easily justified to counteract fluid-shear forces before diaped-
esis can take place. However, in the lymphatic vessel, they are
formed facing the tissue side of the capillary where flow is
negligible. Therefore, we speculate that, in this case, the main
function of the microvilli is to entrap cells near chemotactic
factors. More importantly, the microvilli may provide
increased surface for receptor/ligand interactions that signal
toward the cytoskeleton, such as ushering cells during trans-
migration. In fact, in experiments in which DC b-integrins
were blocked with specific monoclonal antibodies, lateral
drifting and transmigration across lymphatic endothelial
monolayers was severely impaired. These data are reminiscent
of those obtained by W.A Muller who showed how blocking
b-integrins on human monocytes or their ligands on blood
endothelial cells prevented monocytes from reaching the
junctions from which transmigration takes place (Schenkel
et al., 2004).
It is worth mentioning that we observed microvilli projec-
tions ensnaring DCs on both sides of the lymphatic endothe-
lium irrespective of whether paracellular or transcellular
transmigration had occurred. Therefore, these membrane
structures are formed in a nonpolarized manner but seem to
be only dependent on the presence of inflammation-derived
products. b2 Integrin/ICAM-1-mediated intravascular crawling
of DCs on the luminal side of inflamed initial lymphatics
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Figure 5. CCL21 depots appear in close proximity to ICAM-1 microvilli
structures. (a) Representative confocal image of dendritic cells (DCs; red)
adhered to inflamed ICAM-1þ lymphatic endothelial cell (LEC; green) where
CCL21 (blue) staining is detected in close proximity to ICAM-1-enriched LEC
microvilli projections. (b) Quantification of LECs adhered DCs that presented
ICAM-1-enriched microvilli projections after LECs had been preincubated with
a CCL21-blocking mAb or with control IgG. At least 70 cells were analyzed per
condition in 11 different fields. Student’s t-test, **Po0.01. Bar¼ 20mm.
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has been recently described (Nitschke´ M et al., 2012). This result
supports the existence of a common structural mechanism that
involves integrin-mediated cell transit along and across
endothelial layers regardless of the direction of cell migration.
With regard to the mechanisms that may lead to integrin
activation on DC surface, we observed examples of triple
co-distribution of adhered DCs, CCL21 depots, and ICAM-1
clusters on the inflamed endothelial surface. This cytokine
has been reported to drive b-integrins unclasping from low-
to high-affinity conformations (Eich et al., 2011; Shamri et al.,
2005). In our hands, CCL21 preblockade before the addition
of DCs reduced the presence of ICAM-1-enriched LEC
microvilli around DCs, pointing to a functional relationship
between these two events.
Besides, a recent report has demonstrated how CCL21 is
secreted by lymphatic endothelial cells in gradients that attract
DCs toward these capillaries (Weber et al., 2013). Further
research into the precise molecular pathways involved in
lymphatic endothelial cells is clearly warranted.
All in all, these results as a whole show that the lymphatic
endothelium seems to act under inflammation, promoting
active migration of DCs by microvilli projections.
MATERIALS AND METHODS
Lymphatic endothelial cell culture and dendritic cell
differentiation
Primary dermal lymphatic endothelial cells (Clonetics-Lonza, Barce-
lona, Spain) were grown in EGM-2MV medium (Clonetics) as
described (Rouzaut et al., 2010). Cells were used at passages 5–7.
DCs were obtained from CD14þ cells selected by CD14 Microbeads
(Milteny biotec, Madrid, Spain) from healthy donors (Meyer et al.,
2005) and generated with IL-4-GM-CSF or IFN-GM-CSF, as described
(Sallusto and Lanzavecchia, 1994).Informed consent was obtained
after approval from institutional ethics committees Banco de Sangre,
Gobierno de Navarra, and Clı´nica Universidad de Navarra.
Immunofluorescence and confocal analysis
A density of 5 104 LEC cells were seeded on eight-well Labteck
(Nunc, Roskilde, Denmark) slides precoated with 1 mg ml 1 collagen
(BD Bioscience, Madrid, Spain). LEC inflammation was performed by
adding 20 ng ml 1 of TNFa for 16 hours. DCs were stained with 1mM
CMTMR (Life Technologies) on top of LEC monolayers at a 1:1 ratio.
Cocultures were incubated for 15 minutes at 37 1C, and were then
fixed in 3% paraformaldehyde, permeabilized in 0.1% saponin
(in phosphate-buffered saline 3% BSA), and subsequently labeled
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Figure 6. ICAM-1-positive microvilli structures are detected around endogenous dendritic cells (DCs) adhered to lymphatic capillaries from ex vivo–inflamed
human skin samples. (a) Confocal microscopy image reconstructions of ICAM-1 staining (arrow) around an endogenous HLA-DRþ DC (blue) adhered to ex vivo–
inflamed human LYVE-1þ lymphatic vessels (red). Arrowheads: lymphatic endothelial cell (LEC) surface without adhered DCs. Inset: lower magnification where
the structure of the lymphatic vessel is highlighted with a dashed line. Eight DCs presented microvilli structures out of 10 cells visualized. (b) Same as in a, but in
noninflamed samples. It is noteworthy that adhered DCs are not surrounded by LEC-ICAM-1 enrichments. (c) b2-Integrin staining (green, arrow) on DCs (blue) in
contact with LECs (red). (d) Quantification of b2 integrin polarization toward DC/LEC-contacting areas. (e) Immunodetection of mAb24 epitope (green) on DCs
(blue) adhered to LYVE-1þ lymphatic vessels (red). Quantification of (f) mAb24 polarization index, (g) and mean fluorescence intensity (MFI), in DC/LEC contacts.
At least seven cells from two different donors were analyzed per condition. Mann–Whitney U-test, *Po0.05; **Po0.01. Bars¼ 20mm.
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for 45 minutes with the following primary Abs: anti-ICAM-1 mAb
(clone HCD54, Biolegend, San Diego CA), anti CD18 mAb (Abcam,
Cambridge UK), anti-LFA-1 active form mAb24 (HycultBioteck,
Uden, The Netherland), and anti-CCL21 goat polyclonal (R&D),
followed by secondary goat anti-mouse isotype–conjugated antibo-
dies or donkey anti-goat and anti-rabbit antibodies conjugated to
Alexa Fluor-350,-488, and -647 antibodies (all from Life Technolo-
gies, Madrid, Spain). For video microscopy, LEC monolayers were
prestained with Bodipy 630 (Life Technolgies) or anti-ICAM
conjugated to Alexa-488 for 15 minutes before DCs were added.
F-actin was stained with TRITC (Sigma, Madrid, Spain) and Alexa 633
(Life Technologies)–conjugated phalloidin.
For image acquisition, LSM 510 and 710 (Zeiss, Jena, Germany)
inverted confocal microscopes equipped with a  63 plan Apochro-
mat objective (numerical aperture¼ 1.4) were used. Z stacks (20mm)
were taken for fixed specimens. Videos were taken at a controlled
atmosphere of 37 1C and 5% CO2. For single z-plane captures,
photograms were taken at 15-seconds intervals. For z-stack capture,
intervals of 50 seconds between exposures were used. Images were
acquired using the Zeiss software (Aim4 and Zen9). three-
dimensional reconstructions were made using the Volocity Software
(Perkin Elmer, Waltham MA), and images were quantified with
ImageJ and LSM image analyzer (Zeiss).
In some experiments, DCs were blocked for 1 hour using anti-b
integrin (Biolegend)–blocking antibodies at concentrations of
0.1 mg ml 1 for 1 hour at 37 1C. CCL21 blockade was performed
by adding anti-CCL21 polyclonal antibodies (R&D, Barcelona, Spain)
at concentrations of 4 mg ml 1, 2 hours before the experiments.
To simulate nonpolarized conditions, 6 104 LECs were seeded on
top of a 1:1 mixture of collagen type I (from Advanced Biomatrix,
San Diego, CA)/matrigel (BD Biosciences) to subconfluency. Subse-
quently, LECs were coated with a thin mixture of the same
extracellular matrix mixture. Once solidified; CMTMR-stained DCs
were added in culture medium.
Migration assays
Transwell assays were performed as described (Rouzaut et al., 2010),
and blocking of b-integrins was performed as described above.
In vivo LN migration was performed as described elsewhere
(Rouzaut et al., 2010).
Mouse ear whole-mount assays
C57BL/6 male mice were kept in our institutional animal facility in
accordance with ethical guidelines. BM-derived DCs were generated
with GM-CSF as described previously (Rouzaut et al., 2010),
and when indicated they were matured with 500 ng ml 1
lipopolysaccharide for an additional 24 hours. DC crawled assays
were performed as described elsewhere (Stoitzner et al., 2010).
Mouse ear inflammation was performed according to a contact
hypersensibilty (CHS) model as previously described (Vigl et al.,
2011). After 24 hours, the mice were euthanized and the ears were
removed and prepared in custom-made migration chambers.
In all, 106 CMFDA-stained DCs were added onto the ear dermis,
and 3 hours later the samples were washed, fixed in 2%
paraformaldehyde overnight, and permeabilized for 20 minutes with
Triton 0.01%/BSA 3% in phosphate-buffered saline. Samples were
incubated overnight with rabbit anti-mouse LYVE-1(Abcam) and rat
anti-mouse ICAM-1 conjugated with Alexa Fluor-647 (Biolegend)
primary antibodies, followed by incubations with secondary donkey
anti-Rabbit Alexa 594 antibody. Whole-mount preparations were
visualized under a LSM 510 confocal microscope.
Skin explants
Human abdominal skin explants were obtained after written informed
consent was obtained and under ethical approval from
the institutional ethics committee (Clinica Universidad de Navarra),
in adherence to the Declaration of Helsinki Principles that involves
human samples. Tissue explants were incubated for 24 hours on
AIM-V serum-free medium supplemented with 100 ng ml 1 TNFa
and 50 ng ml 1 GM-CSF to induce inflammation. After 24 hours,
20 ng ml 1 CCL21 was added to the culture medium and
500 ng ml 1 lipopolysaccharide was injected under the skin. After
24 hours, human samples were stained with rabbit anti-human
LYVE-1 (Abcam), mouse anti-human ICAM-1 mAb (Biolegend),
mouse anti-human b2 integrin (Abcam), mouse anti-human mAb24
(HycultBioteck), and mouse anti-human HLA-DR mAb (clone L243
supernatant HB-55, ATCC, Manassas, VA), followed by appropriate
isotype-specific secondary goat anti-mouse antibodies or donkey
anti-rabbit antibodies conjugated to Alexa Fluor 488,594, and 647
(Life technologies). Images were taken on a LSM 510 confocal
microscope.
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